Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
23,774,879
-
Share change
-
-2,872,072
-
Total reported value
-
$42,318,000
-
Put/Call ratio
-
54200%
-
Price per share
-
$1.78
-
Number of holders
-
36
-
Value change
-
-$10,528,580
-
Number of buys
-
20
-
Number of sells
-
13
Institutional Holders of ASLAN PHARMACEUTICALS LTD - ADS (ASLN) as of Q3 2021
As of 30 Sep 2021,
ASLAN PHARMACEUTICALS LTD - ADS (ASLN) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,774,879 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Vivo Capital, LLC, CITADEL ADVISORS LLC, MANGROVE PARTNERS, ORBIMED ADVISORS LLC, Temasek Holdings (Private) Ltd, MILLENNIUM MANAGEMENT LLC, Sio Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, and PLATINUM INVESTMENT MANAGEMENT LTD.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.